Back to all news
AnalysisRKLB

Rocket Lab — 3 Houses Trim Targets After Q3 | Neutron Timing Is the Key Variable

Published · Updated · By Investus editorial desk (SUNRYU Partners)

Three houses trimmed Rocket Lab price targets after Q3 earnings: Cantor Fitzgerald ($122→$111, Overweight), Barclays ($85→$82, Overweight), Piper Sandler ($83→$58, Neutral). All three cite Neutron rocket timing as the core variable. Two of three maintain Overweight — the long-term case is intact.

Rocket Lab — 3 Houses Trim Targets After Q3 | Neutron Timing Is the Key Variable

What happened

Post-Q3 earnings, three firms adjusted Rocket Lab price targets (all trims, per TipRanks Post-Earnings Roundup):

Cantor Fitzgerald: $122 → $111 (Overweight maintained). Key takeaway: 'Attractive entry ahead of Neutron.' Barclays: $85 → $82 (Overweight maintained). Key takeaway: 'Record bookings, higher Neutron pricing.' Piper Sandler: $83 → $58 (Neutral). Key takeaway: 'Neutron timing is the key metric.'

More detail

The common thread: Neutron medium-lift rocket development timeline uncertainty. Neutron is Rocket Lab's step-change — when operational, it multiplies the addressable market and revenue scale. The current Electron small-launch business is healthy (record bookings confirmed), but the valuation upside requires Neutron to deliver.

The positive read: 2 of 3 houses kept Overweight, meaning the long-term bull case — Electron recurring revenue → Neutron large contracts → satellite manufacturing expansion — is still considered intact. 'Higher Neutron pricing' suggests Rocket Lab has pricing power in advance contracts, which is fundamentally bullish for Neutron economics.

Piper Sandler's Neutral reflects the view that at current pricing, the risk/reward balance is less compelling until Neutron timing becomes clearer.

Analyst and house views

The wide target range ($58–$111) captures the Neutron success/delay binary outcome directly. Neutron's first flight date and initial customer announcements are the top 2027 catalysts.

investus Research

Sources & further reading

Related articles

Email the morning brief

Disclaimer

This article is editorial research for informational purposes only. It is not investment advice, a recommendation, or a solicitation to buy or sell any security, and does not guarantee any return. Markets carry risk of loss. Verify figures against the primary sources before making decisions.

View Past Sessions